Correction to Substrate-Based Fragment Identification for the

Dec 12, 2014 - In the right column, line 7, the designation. “1R,2S,5R” should be “1S,2R,5S”. Page 7641. In Scheme 6, the structure of Mnt was...
0 downloads 0 Views 112KB Size
Addition/Correction pubs.acs.org/jmc

Correction to Substrate-Based Fragment Identification for the Development of Selective, Nonpeptidic Inhibitors of StriatalEnriched Protein Tyrosine Phosphatase Tyler D. Baguley, Hai-Chao Xu, Manavi Chatterjee, Angus C. Nairn, Paul J. Lombroso, and Jonathan A. Ellman* Journal of Medicinal Chemistry 2013, 56, 7636−7650. DOI: 10.1021/jm401037h The structures and absolute configurations of all inhibitors reported in the manuscript are correct. However, in the discussion on the preparation of the stereoisomeric inhibitors 12s−v, L-menthol should replace D-menthol as indicated below: Page 7640. In the right column, line 7, the designation “1R,2S,5R” should be “1S,2R,5S”. Page 7641. In Scheme 6, the structure of Mnt was incorrectly drawn. L-Menthol rather than the D-enantiomer should be shown. Page 7648. In the left column, lines 44, 46, 48 and 56, the designation “1R,2S,5R” should be “1S,2R,5S”.

Published: December 12, 2014 © 2014 American Chemical Society

10564

dx.doi.org/10.1021/jm5018847 | J. Med. Chem. 2014, 57, 10564−10564